Pages that link to "Q90100203"
Jump to navigation
Jump to search
The following pages link to Cholecystokinin 2 Receptor Agonist 177Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma: Results of the Lumed Phase 0a Study (Q90100203):
Displaying 1 item.
- The Association Between Lymph Node Stage and Clinical Prognosis in Thyroid Cancer (Q90345031) (← links)